XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Cash Flow Statements - EUR (€)
€ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities    
Net profit / (loss) for the period € (110,914) € (125,498)
Reversal of finance income (45,135) (13,044)
Reversal of finance expenses 9,840 5,399
Reversal of gain and loss on disposal of property, plant and equipment 21 0
Reversal of income taxes (expenses) 1,297 241
Increase / (decrease) in provisions 1,983 1,215
Adjustments for non-cash items:    
Non-cash consideration relating to revenue (614) (632)
Share of profit / (loss) of associate 1,227 4,873
Share-based payment 13,688 19,968
Depreciation 4,435 4,304
Amortization 111 111
Changes in working capital:    
Inventories (20,178) (17,031)
Receivables (9,608) (2,407)
Prepayments (10,176) (2,728)
Contract liabilities (deferred income) (256) (2,338)
Trade payables, accrued expenses and other payables 14,236 (4,338)
Cash flows generated from / (used in) operations (150,043) (131,905)
Finance income received 3,879 1,848
Finance expenses paid (906) (610)
Income taxes received / (paid) 26 (121)
Cash flows from / (used in) operating activities (147,044) (130,788)
Investing activities    
Acquisition of property, plant and equipment (1,085) (3,818)
Reimbursement from acquisition of property, plant and equipment 0 3,794
Purchase of marketable securities 0 (26,311)
Settlement of marketable securities 211,731 64,877
Cash flows from / (used in) investing activities 210,646 38,542
Financing activities    
Payment of principal portion of lease liabilities (2,568) (1,950)
Net proceeds from convertible senior notes 0 504,454
Proceeds from exercise of warrants 1,866 385
Acquisition of treasury shares, net of transaction costs 0 (105,154)
Cash flows from / (used in) financing activities (702) 397,735
Increase / (decrease) in cash and cash equivalents 62,900 305,489
Cash and cash equivalents at January 1 444,767 446,267
Effect of exchange rate changes on balances held in foreign currencies (6,386) 3,887
Bank deposits 501,281 754,497
Short-term marketable securities 0 1,146
Cash and cash equivalents at March 31 € 501,281 € 755,643